Resuscitation fluids in critical care
|
|
|
- Jeremy Owens
- 6 years ago
- Views:
Transcription
1 Resuscitation fluids in critical care John A Myburgh MBBCh PhD FCICM UNSW Professor of Critical Care Medicine The George Institute for Global Health University of New South Wales St George Hospitals, Sydney
2
3
4 The Great Fluid Debate I don t care if you use dog s piss, as long as you use it carefully. Malcolm Fisher AO
5 Roberts: BMJ 1998
6 Hypovolaemia 24/30 studies n=1104/1419 Burns Hypoalbuminaemia RRD 1.68 ( ) Overall excess mortality of 6% (95% C.I. 3-9%) TOTAL Favours albumin Favours control Roberts: BMJ 1998
7
8 I would attempt to sue anyone who gave me an albumin infusion. And, as for any attempt to secure my informed consent to take part in a randomised trial... forget it! Chalmers BMJ:1998
9 The SAFE study ANZICS Clinical Trials Group New Eng J Med: 2004: 350:
10 The SAFE study Double-blind, randomised trial 4% albumin vs 0.9% saline for all volume resuscitation in the Intensive Care Unit 16 Intensive Care Units in Australia and New Zealand Powered to detect 3% difference in absolute mortality from an estimated baseline of 15% (β=0.1, =0.05) n=7000 Stratified by an admission diagnosis of trauma SAFE Investigators: NEJM 2004
11 Methodology
12 MAP(mmHg) Serum albumin (g/l) MAP(mmHg) Beats per minutes Resuscitation endpoints 125 * Mean arterial pressure 125 * * Heart rate Albumin Saline * p<0.001 Baseline Day Central venous pressure Baseline Day Serum albumin 20 # * * * * * * * * # p=0.033 * p< * p<0.001 Baseline Day Baseline Day SAFE Investigators: NEJM 2004
13 Volume administered (ml) Fluid volumes p<0.001 p<0.001 Albumin Saline 500 p= Day Ratio of albumin to saline for first four days = 1:1.4 SAFE Investigators: NEJM 2004
14 Outcomes SAFE Investigators: NEJM 2004
15 Should you change practice?
16 SAFE: trauma subset P=0.039 (Test for common relative risk) SAFE Investigators: NEJM 2004
17 Mortality (%) Mortality (%) Trauma and traumatic brain injury p=0.009 Albumin Saline 20 p= / / /240 81/596 38/ / /356 21/ Trauma Without trauma Trauma with TBI Trauma without TBI n=22 n=21 SAFE Investigators: NEJM 2004
18 Mortality at 28 days Mortality at 2 years SAFE Study Investigators New Eng J Med: 2007
19 Albumin and sepsis
20 What about synthetic colloids?
21 Colloids v crystalloids Colloid Trials n RR 95%CI Albumin to 1.10 HES to 1.75 Gelatin to 1.72 Dextran to 1.65 Perel: Cochrane Collaboration 2007
22 Colloids for resuscitation Colloid Trials n RR 95%CI Albumin v HES to 1.43 Albumin v gelatin to 1.39 Albumin v dextran to Gelatin v HES to 1.25 Bunn: Cochrane Collaboration 2009
23 SAFE TRIPS SAFE TRIPS Investigators: Crit Care 2010
24 Resuscitation episodes SAFE TRIPS 2500 Starch Albumin Gelatin Dextran Countries, 391 Intensive Care Units single day in / 5339 (36.8%) patients received fluid resuscitation 0 Crystalloid Colloid SAFE TRIPS Investigators: Crit Care 2010
25 Fluid type by country / region SAFE TRIPS Investigators: Crit Care 2010
26 Fluid volumes SAFE TRIPS Investigators: Crit Care 2010
27 ml per person Colloid use in severe sepsis Choice of Severe sepsis Choice of Colloid: Severe sepsis Albumin Starch Gelatin Dextran OCEANIA AMERICAS ASIA NORTHERN EUROPE SOUTHERN EUROPE WESTERN EUROPE All SAFE TRIPS Investigators: Crit Care 2010
28 Starch and nephrotoxicity 3% Gelatin 6% HES (200/ ) 3% Gelatin 6% HES (200/ ) Log rank p=0.018 Log rank p=0.29 n=129 Proportion without ARF Proportion survival Schortgen: Lancet 2001
29 Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP) 10% Pentastarch (200/0.5) YES NO Intensive insulin therapy YES IIT + PS IIT NO PS Neither P=0.48 P=0.09 Open label, RCT: 10% ARR in 28d mortality N= (adaptive design) Renal replacement therapy: 31.0 v 18.8% p=0.001 Brunkhorst: New Engl J Med 2008
30 HES: effects on renal function Outcome Trials n RR 95%CI Renal replacement therapy to 2.16 RRT : sepsis to 2.1 Author-defined ARF to 1.87 Author-defined ARF: sepsis to 1.96 Dart: Cochrane Collaboration 2010
31 CVVHDF Requirement (%) Are newer starches different? Evidence of safety? CrCL 15-<50 CrCL mL bolus 6% HES 130/ Reduced accumulation in renal dysfunction Jungheinrich Anesth Analg HES 130/0.4 HES 200/0.5 Renal function in ICU Retrospective observational study: n=8408 (4yrs) Brimer: abstract ESICM 2008
32 Are newer starches different? Evidence of benefit? Favors 130/0.4 Favors 200/0.5 Blood loss in high risk surgery Kozek: Anes Analg 2008 Immunomodulation in ischaemia-reperfusion injury Varga: Crit Care Med 2008
33 ANZICS Clinical Trials Group
34 Design and outcomes Clinicaltrials.gov : GI-CCT24378 CHEST MC: Intensive Care Medicine Jan 2011
35 Aim CHEST To determine the effects of intravenous fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in 0.9% sodium chloride solution compared to 0.9% sodium chloride alone on all-cause mortality in critically ill patients. Design Blinded, multicentred, randomised-controlled trial Power N=7000 To detection ARR 3.5% from baseline mortality of 21% (α=0.05; β0.9) To detect RRI in renal failure by 1.3 from baseline of 6%. Outcomes All-cause mortality at 90 days Incidence of acute renal injury/acute renal failure Interval mortality rates Organ failures (respiratory, cardiovascular, coagulation and hepatic) Quality of life and functional outcome assessments Cost-effectiveness analysis
36 Joachim Boldt
37 Shafer: Anes Analg March 2011
38 Acta Anethesoiologica Scancinavia :3 Anaesthesia: 6 Anasthesiolgie Intensivmedizin Notfallmedizin Schmerzterapie: 6 Anesthesia and Analgesia: 22 Anesthesiology: 1 Annals of Thoracic Surgery: 2 BritishJournal of Anaesthesia: 11 Canadian Journal of Anaesthesia: 5 Critical Care Medicine: 2 Der Anesthesist: 2 European Journal of Anaesthesiology: 8 Intensive Care Medicine: 5 Journal of Cardiothoracic and Thoracic Anaesthesia: 12 Journal of Cranio-Maxillary-Facial Surgery: 1 Medical Science Monitor: 2 Minerva Anesthesiolgica: 1 The Thoracic and Cardiovascular Surgeon: 1 Vox Sanguinis: 1
39
40 6% HES (130/0.4) systematic review
41 Cochrane updates 2011
42 What about crystalloids? Abnormal saline vs Balanced salt solutions
43 Guidelines.. 28 evidence- based, consensus recommendations Fluid resuscitation Peri-operative fluid management Intra-operative fluid management Post-operative fluid and nutritional management Fluid management in acute renal injury
44 Fluid resuscitation Seven references all pre date SAFE: 3 volunteer studies 2 review articles 2 randomised trials: n=68 Secondary outcomes NOT level 1 Sensible maybe, but eminence based
45 SAFE and acid base Nested, cohort study within the SAFE study N=691, 3 general ICUs Volume of fluid is predictor of acid base change Changes are minor alkalosis predominates Influenced by disease severity and time Bellomo: Crit Care Med 2006
46 Conclusions The crystalloid colloid debate continues unabated Apart from the SAFE study, there is little high-quality evidence to guide the prescription and administration of the majority of resuscitation fluids given to critically ill patients in Australia and globally.
47 So, which fluid should I use?? On the weight of published, high-quality evidence, crystalloid, specifically normal saline, is the resuscitation fluid of choice for critically ill patients. There is no evidence of benefit of one crystalloid over another in terms of improving patient-centred outcomes.
48 So, which fluid should I use?? With respect to colloids, albumin should not be used for the resuscitation of patients with traumatic brain injury. Whether albumin confers a benefit in patients with severe sepsis requires further study. There is no justification for the use of synthetic colloids for resuscitation outside the context of randomised-controlled trials.
49 And so. There is an intellectual and ethical imperative to continue to conduct high-quality studies about one of the most common interventions in acute medicine. Australian and New Zealand researchers continue to lead the field in this area through the ANZICS Clinical Trials Group and collaborators.
50
Fluid resuscitation in specific patient populations: sepsis and traumatic brain injury
Fluid resuscitation in specific patient populations: sepsis and traumatic brain injury John A Myburgh MBBCh PhD FCICM UNSW Professor of Critical Care Medicine The George Institute for Global Health University
Fluid Treatments in Sepsis: Meta-Analyses
Fluid Treatments in Sepsis: Recent Trials and Meta-Analyses Lauralyn McIntyre MD, FRCP(C), MSc Scientist, Ottawa Hospital Research Institute Assistant Professor, University of Ottawa Department of Epidemiology
Fluids in ICU. JMO teaching 5th July 2016
Fluids in ICU JMO teaching 5th July 2016 Objectives Physiology of fluid infusion History of fluid resuscitation Physiology of fluid resuscitation Types of resuscitation fluid The ideal resuscitation fluid
Update in Critical Care Medicine
Update in Critical Care Medicine Michael A. Gropper, MD, PhD Professor and Executive Vice Chair Department of Anesthesia and Perioperative Care Director, Critical Care Medicine UCSF Disclosure None Update
Hydroxyethyl starch and bleeding
Hydroxyethyl starch and bleeding Anders Perner Dept. of Intensive Care, Rigshospitalet University of Copenhagen Scandinavian Critical Care Trials Group Intensive Care Medicine COIs Ferring, LFB - Honoraria
Albumin: rationale, use and evidence
Albumin: rationale, use and evidence Michaël Chassé, MD, MSc, FRCPC Intensivist, CHU de Québec PhD Candidate, Epidemiology, uottawa Research Fellow, Clinical Epidemiology Program Ottawa Hospital Research
FLUID RESUSCITATION SUMMARY
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care
Comment on infusion solutions containing HES
Comment on infusion solutions containing HES The European Medicines Agency (EMA) published on 14 June 2013 Pharmacovigilance Risk Assessment Committee (PRAC) recommends suspending marketing authorisations
Maria B. ALBUJA-CRUZ, MD ALBUMIN: OVERRATED. Surgical Grand Rounds
Maria B. ALBUJA-CRUZ, MD ALBUMIN: OVERRATED Surgical Grand Rounds ALBUMIN Most abundant plasma protein 1/3 intravascular 50% of interstitial SKIN Synthesized in hepatocytes Transcapillary escape rate COP
What is the Role of Albumin in Sepsis? An Evidenced Based Affair. Justin Belsky MD PGY3 2/6/14
What is the Role of Albumin in Sepsis? An Evidenced Based Affair Justin Belsky MD PGY3 2/6/14 Microcirculation https://www.youtube.com/watch?v=xao1gsyur7q Capillary Leak in Sepsis Asking the RIGHT Question
What is the right fluid to use?
What is the right fluid to use? L McIntyre Associate Professor, University of Ottawa Senior Scientist, Ottawa Hospital Research Institute Centre for Transfusion Research CCCF, November 2, 2016 Disclosures
JOURNAL CLUB: THE FLUIDS DEBATE. Veronica Ueckermann
JOURNAL CLUB: THE FLUIDS DEBATE Veronica Ueckermann INTRODUCTION The selection and use of resuscitation fluids should be based on physiological principles. However, historically, clinical practice has
Haemodynamic and biochemical responses to fluid bolus therapy with human albumin solution, 4% versus 20%, in critically ill adults
Haemodynamic and biochemical responses to fluid bolus therapy with human albumin solution, 4% versus 20%, in critically ill adults Jonathan Bannard-Smith, Paschal Alexander, Neil Glassford, Matthew J Chan,
Modern fluid therapy. Anders Perner. Dept of Intensive Care, Rigshospitalet, University of Copenhagen
Modern fluid therapy Anders Perner Dept of Intensive Care, Rigshospitalet, University of Copenhagen Scandinavian Critical Care Trials Group www.ssai.info/research/scctg Intensive Care Medicine www.icmjournal.esicm.org
Approach to Severe Sepsis. Jan Hau Lee, MBBS, MRCPCH. MCI Children s Intensive Care Unit KK Women s and Children's Hospital, Singapore
Approach to Severe Sepsis Jan Hau Lee, MBBS, MRCPCH. MCI Children s Intensive Care Unit KK Women s and Children's Hospital, Singapore 1 2 No conflict of interest Overview Epidemiology of Pediatric Severe
Albumina nel paziente critico. Savona 18 aprile 2007
Albumina nel paziente critico Savona 18 aprile 2007 What Is Unique About Critical Care RCTs patients eligibility is primarily defined by location of care in the ICU rather than by the presence of a specific
Evidence-Based. Management of Severe Sepsis. What is the BP Target?
Evidence-Based Management of Severe Sepsis Michael A. Gropper, MD, PhD Professor and Vice Chair of Anesthesia Director, Critical Care Medicine Chair, Quality Improvment University of California San Francisco
J v /A = L p { (P c - P i ) σ (π p - π i ) } 7/13/14. Current Concepts and Controversies in Small Animal Critical Care. Goals and Objec.
The Crystalloid vs. Colloid Controversy Continues Karl E. Jandrey, DVM, MAS, DAVCECC Associate Professor of Clinical Small Animal Emergency & Critical Care 2 nd Annual Conti Symposium, UC Irvine August
Practical fluid therapy in companion animals part 1
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Practical fluid therapy in companion animals part 1 Author : Rebecca Robinson Categories : Companion animal, Vets Date : September
Journal Club ICU
Journal Club 2018.9.4 ICU Crit Care Med. 2018 Aug;46(8):1224-1229 Introduction Stress hyperglycemia SH SH >124 mg/dl or >200 mg/dl Lancet 2009;373:1798. stress hyperglycemia Lancet 2009;373:1798. SH Critical
Getting smart with fluids in the critically ill. NOR AZIM MOHD YUNOS Jeffrey Cheah School of Medicine & Health Sciences Monash University Malaysia
Getting smart with fluids in the critically ill NOR AZIM MOHD YUNOS Jeffrey Cheah School of Medicine & Health Sciences Monash University Malaysia Isotonic Solutions and Major Adverse Renal Events Trial
LESSONS FROM EVIDENCE BASED MEDICINEIN THE CARE OF ARF AND ESRD. Prof. Dr. Adrian Covic University of Medicine Gr. T. Popa, Iaşi
LESSONS FROM EVIDENCE BASED MEDICINEIN THE CARE OF ARF AND ESRD 2008 Prof. Dr. Adrian Covic University of Medicine Gr. T. Popa, Iaşi Effect of acute renal failure requiring renal replacement therapy on
Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care
original article Hydroxyethyl Starch or for Fluid Resuscitation in Intensive Care John A. Myburgh, M.D., Ph.D., Simon Finfer, M.D., Rinaldo Bellomo, M.D., Laurent Billot, M.Sc., Alan Cass, M.D., Ph.D.,
Chapter 3 MAKING THE DECISION TO TRANSFUSE
Chapter 3 MAKING THE DECISION TO TRANSFUSE PRACTICE POINTS Determine the best treatment for the patient which may include transfusion. Treat the cause of cytopenia (anaemia or thrombocytopenia) or plasma
Intravenous Fluid Therapy in Critical Illness
Intravenous Fluid Therapy in Critical Illness GINA HURST, MD DIVISION OF EMERGENCY CRITICAL CARE HENRY FORD HOSPITAL DETROIT, MI Objectives Establish goals of IV fluid therapy Review fluid types and availability
Managing Patients with Sepsis
Managing Patients with Sepsis Diagnosis; Initial Resuscitation; ARRT Initiation Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum
Fluids Watch the type and measure the quantity
Critical Care Medicine Apollo Hospitals Fluids Watch the type and measure the quantity Ramesh Venkataraman, AB (Int. Med), AB (CCM) Senior Consultant, Critical Care Medicine Apollo Hospitals Chennai My
Acute Kidney Injury for the General Surgeon
Acute Kidney Injury for the General Surgeon UCSF Postgraduate Course in General Surgery Maui, HI March 20, 2011 Epidemiology & Definition Pathophysiology Clinical Studies Management Summary Hobart W. Harris,
Kristan Staudenmayer, MD Stanford University, Stanford, CA
Kristan Staudenmayer, MD Stanford University, Stanford, CA Fluid resuscitation Variety of fluids How to administer What you do DOES matter WWII 1942 North Africa high mortality from hemorrhaghic shock
Intravenous fluid use after cardiac surgery: a multicentre, prospective, observational study
Intravenous fluid use after cardiac surgery: a multicentre, prospective, observational study Rachael L Parke, Shay P McGuinness, Eileen Gilder and Lianne W McCarthy The optimal use of postoperative intravenous
Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE
Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE In critically ill patients: too little fluid Low preload,
Fluid resuscitation in the ICU/sepsis. The use of albumin
Fluid resuscitation in the ICU/sepsis The use of albumin Overview Introduction to the ICU and sepsis Albumin: rationale for use in the ICU and severe sepsis Albumin: effects on mortality in sepsis and
Fluid Resuscitation in Sepsis. A Literature Review
Fluid Resuscitation in Sepsis A Literature Review "On the floor lay a girl of slender make and juvenile height, but with the face of a superannuated hag... The colour of her countenance was that of lead
Salt of the earth or a drop in the ocean An overview of the properties of iv fluids
Bapen Conference 2009 13 th October 2009 Cardiff International Arena Salt of the earth or a drop in the ocean An overview of the properties of iv fluids Peter Gosling BSc MSc PhD FRCPath Consultant Clinical
Transfusion & Mortality. Philippe Van der Linden MD, PhD
Transfusion & Mortality Philippe Van der Linden MD, PhD Conflict of Interest Disclosure In the past 5 years, I have received honoraria or travel support for consulting or lecturing from the following companies:
Fluid Management in the Critically-Ill
Fluid Management in the Critically-Ill Dan Schuller, M.D. Professor and Chair Department of Internal Medicine - Transmountain Texas Tech University Health Sciences Center El Paso Paul L. Foster School
Current issues in Volume therapy
CCM Inter-Hospital Grand Round Hong Kong, May 22, 2012 Current issues in Volume therapy Dr. Hrishikesh Kulkarni Medical Director Fresenius Kabi Asia Pacific, Hong Kong Controversies in Intravenous fluids
IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London
IV fluid administration in sepsis Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London The talk What is septic shock? What are the recommendations? What is the evidence? Do we follow
Steroid in Paediatric Sepsis. Dr Pon Kah Min Hospital Pulau Pinang
Steroid in Paediatric Sepsis Dr Pon Kah Min Hospital Pulau Pinang Contents Importance of steroid in sepsis Literature Review for adult studies Literature Review for paediatric studies Conclusions. Rationale
Title: IV Colloid Plasma Volume Expanders for Hypovolemia. Date: May 15, 2007
Title: IV Colloid Plasma Volume Expanders for Hypovolemia Date: May 15, 2007 Research question: What is the clinical effectiveness of intravenous colloid plasma volume expanders for patients with profound
Albumin in Cardiac Surgery
Albumin in Cardiac Surgery A Natural Colloid for Perioperative Fluid Management January 2014 Overview Introduction to cardiac surgery Hypoalbuminaemia: predictor of poor outcome in cardiac surgery Albumin
Fluid management of Neurosurgical patient, Recent update
Fluid management of Neurosurgical patient, Recent update Catholic University of Daegu Department of anesthesiology and pain medicine Taeha. Ryu. Fluid management of Neurosurgical patient The major aims.
Fencl Stewart analysis of acid base changes immediately after liver transplantation
Fencl Stewart analysis of acid base changes immediately after liver transplantation David A Story, Rakesh Vaja, Stephanie J Poustie and Larry McNicol The acid base changes associated with liver transplantation
Actualités sur le remplissage peropératoire. Philippe Van der Linden MD, PhD
Actualités sur le remplissage peropératoire Philippe Van der Linden MD, PhD Fees for lectures, advisory board and consultancy: Fresenius Kabi GmbH B Braun Medical SA Perioperative Fluid Volume Administration
Sepsis Management Update 2014
Sepsis Management Update 2014 Laura J. Moore, MD, FACS Associate Professor, Department of Surgery The University of Texas Health Science Center, Houston Medical Director, Shock Trauma ICU Texas Trauma
Fluid Therapy and Outcome: Balance Is Best
The Journal of ExtraCorporeal Technology Fluid Therapy and Outcome: Balance Is Best Sara J. Allen, FANZCA, FCICM Department of Anaesthesia and the Cardiothoracic and Vascular Intensive Care Unit, Auckland
Can Goal Directed Sedation Improve Outcomes?
Can Goal Directed Sedation Improve Outcomes? Yahya SHEHABI, FANZCA, FCICM, EMBA Professor and Program Director Critical care Monash Health and Monash University - Melbourne School of Medicine, University
Fluid balance in Critical Care
Fluid balance in Critical Care By Dr HP Shum Nephrologist and Critical Care Physician Department of Intensive Care, PYNEH Fluid therapy is a critical aspect of initial acute resuscitation in critically
Fluid therapy using a balanced crystalloid solution and acid base stability after cardiac surgery
Fluid therapy using a balanced crystalloid solution and acid base stability after cardiac surgery Roger J Smith, David A Reid, Elizabeth F Delaney and John D Santamaria There is increasing interest in
Anaemia in the ICU: Is there an alternative to using blood transfusion?
Anaemia in the ICU: Is there an alternative to using blood transfusion? Tim Walsh Professor of Critical Care, Edinburgh University World Health Organisation grading of the severity of anaemia Grade of
A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study
A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study Sumeet K Reddy, Michael J Bailey, Richard W Beasley, Rinaldo Bellomo, Seton J Henderson, Diane M Mackle,
Standard Operating Procedure (SOP) Management of intervention group patients SOP 001
` Standard Operating Procedure (SOP) Management of intervention group patients SOP 001 Authors: Mark Edwards & Rupert Pearse Authorisation: Rupert Pearse (Chief Investigator) Scope To provide guidance
Albumin Regulation and Reimbursement
FACULTY OF MEDICINE, DENTISTRY AND HEALTH SCIENCES Albumin Regulation and Reimbursement ALBERT FARRUGIA, ADJUNCT PROFESSOR, DEPARTMENT OF SURGERY Disclosures Compensated contractual services to the biotherapeutics
Fluid assessment, monitoring and therapy for the acute nurse
Fluid assessment, monitoring and therapy for the acute nurse Kelly Wright Lead Nurse for AKI King s College Hospital Aims and objectives Aims and objectives Why do we worry about volume assessment? Completing
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill
Back to the Future: Updated Guidelines for Evaluation and Management of Adrenal Insufficiency in the Critically Ill Joe Palumbo PGY-2 Critical Care Pharmacy Resident Buffalo General Medical Center Disclosures
Fluids in Sepsis Less is more. Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth,
Fluids in Sepsis Less is more Dr Anand Senthi Joondalup Health Campus ED MBBS, MAppFin, GradCertPubHlth, FRACGP @drsenthi Summary Discussion of the evidence for/against fluid resuscitation in septic shock
Fluids and Lactate. A/Prof Peter Morley
Fluids and Lactate A/Prof Peter Morley RCTs Other evidence 5 6 Plan Background information Crystalloids Which crystalloid? Colloids Crystalloids v colloids Once that s settled, how much fluid Plan Background
How and why I give IV fluid Disclosures SCA Fluids and public health 4/1/15. Andrew Shaw MB FRCA FCCM FFICM
How and why I give IV fluid Andrew Shaw MB FRCA FCCM FFICM Professor and Chief Cardiothoracic Anesthesiology Vanderbilt University Medical Center 2015 Disclosures Consultant for Grifols manufacturer of
Renal failure in sepsis and septic shock
Renal failure in sepsis and septic shock Dr. Venugopal Reddy. MD, EDIC, FCARCSI Associate Professor of Anesthesiology and Critical Care medicine Department of Anaesthesia and CCM Penn State College of
The History & Practice of IV Fluid Therapy have we advanced in 185 years?
The History & Practice of IV Fluid Therapy have we advanced in 185 years? Liam Plant Clinical Professor of Renal Medicine University College Cork Consultant Renal Physician Cork University Hospital National
Rationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale
Rationale for renal replacement therapy in ICU: indications, approaches and outcomes Richard Beale RIFLE classification (ADQI group) 2004 Outcome AKIN classification Definition: Abrupt (within 48 hrs)
Dr. Nai Shun Tsoi Department of Paediatric and Adolescent Medicine Queen Mary Hospital Hong Kong SAR
Dr. Nai Shun Tsoi Department of Paediatric and Adolescent Medicine Queen Mary Hospital Hong Kong SAR A very important aspect in paediatric intensive care and deserve more attention Basic principle is to
Wales Critical Care & Trauma Network (North) Management of Hyponatraemia in Intensive Care Guidelines
Wales Critical Care & Trauma Network (North) Management of Hyponatraemia in Intensive Care Guidelines Author: Richard Pugh June 2015 Guideline for management of hyponatraemia in intensive care Background
John Park, MD Assistant Professor of Medicine
John Park, MD Assistant Professor of Medicine Faculty photo will be placed here park.john@mayo.edu 2015 MFMER 3543652-1 Sepsis Out with the Old, In with the New Mayo School of Continuous Professional Development
Sepsis Management: Past, Present, and Future
Sepsis Management: Past, Present, and Future Benjamin Ferrell, MD Tennessee ACP Meeting October 28, 2017 Learning Objectives Identify the most updated definition and clinical criteria for sepsis Describe
Disclosures. Glycemic Control in the Intensive Care Unit. Objectives. Hyperglycemia. Hyperglycemia. History. No disclosures
Disclosures Glycemic Control in the Intensive Care Unit No disclosures Jorie Frasiolas, Pharm.D., BCPS Clinical Pharmacy Manager, CTICU NewYork-Presbyterian Hospital Columbia University Medical Center
Postoperative hypothermia and patient outcomes after elective cardiac surgery
doi:10.1111/j.1365-2044.2011.06784.x ORIGINAL ARTICLE Postoperative hypothermia and patient outcomes after elective cardiac surgery D. Karalapillai, 1 D. Story, 2 G. K. Hart, 3,4 M. Bailey, 5 D. Pilcher,
INTRAVENOUS FLUID THERAPY. Tom Heaps Consultant Acute Physician
INTRAVENOUS FLUID THERAPY Tom Heaps Consultant Acute Physician LEARNING OBJECTIVES 1. Crystalloids vs colloids 2. Balanced vs non-balanced solutions 3. Composition of various IV fluids 4. What is normal
Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis
Intensive Care Med (2015) 41:257 264 DOI 10.1007/s00134-014-3593-0 ORIGINAL Nor azim Mohd Yunos Rinaldo Bellomo Neil Glassford Harvey Sutcliffe Que Lam Michael Bailey Chloride-liberal vs. chloride-restrictive
ROBERT SÜMPELMANN MD, PhD*, LARS WITT MD*, MEIKE BRÜTT MD*, DIRK OSTERKORN MD, WOLFGANG KOPPERT MD, PhD* AND WILHELM A.
Pediatric Anesthesia 21 2: 1 14 doi:1.1111/j.146-9592.29.3197.x Changes in acid-base, electrolyte and hemoglobin concentrations during infusion of hydroxyethyl starch 13.42 6 : 1 in normal saline or in
Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP
Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis
Presented by: Indah Dwi Pratiwi
Presented by: Indah Dwi Pratiwi Normal Fluid Requirements Resuscitation Fluids Goals of Resuscitation Maintain normal body temperature In most cases, elevate the feet and legs above the level of the heart
I Suggest Abnormal Saline
I Suggest Abnormal Saline Sean M Bagshaw, MD, MSc Division of Critical Care Medicine University of Alberta CCCF Oct 27, 2015 2015 Disclosures Salary support: Canada/Alberta government Grant support: Canada/Alberta
Fluid balance and clinically relevant outcomes
Fluid balance and clinically relevant outcomes Rui Moreno, MD, PhD, Professor UCINC, Hospital de São José Centro Hospitalar de Lisboa Central, E.P.E. INSULT PRIMARY MODS SIRS SECONDARY MODS OUTCOME RECOVERY
Impact of Fluids in Children with Acute Lung Injury
Impact of Fluids in Children with Acute Lung Injury Canadian Critical Care Forum Toronto, Canada October 27 th, 2015 Adrienne G. Randolph, MD, MSc Critical Care Division, Department of Anesthesia, Perioperative
BAXTER LAUNCHES FIRST 3-IN-1 SET FOR USE IN CONTINUOUS RENAL REPLACEMENT THERAPY AND SEPSIS MANAGEMENT PROTOCOLS
FOR IMMEDIATE RELEASE Media Contact Beth Mueller, (224) 948-5353 media@baxter.com Investor Contact Clare Trachtman, (224) 948-3085 BAXTER LAUNCHES FIRST 3-IN-1 SET FOR USE IN CONTINUOUS RENAL REPLACEMENT
VI.2 ELEMENTS FOR A PUBLIC SUMMARY (VOLUVEN 10%)
VI.2 ELEMENTS FOR A PUBLIC SUMMARY (VOLUVEN 10%) VI.2.1 OVERVIEW OF DISEASE EPIDEMIOLOGY Hypovolaemia is a state of decreased or reduced circulating blood volume which can be caused by a number of medical
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Intravenous fluid therapy in adults in hospital Quality standard title: Intravenous fluid
Sepsis. National Clinical Guideline Centre. Sepsis: the recognition, diagnosis and management of sepsis. NICE guideline <number> January 2016
National Clinical Guideline Centre Consultation Sepsis Sepsis: the recognition, diagnosis and management of sepsis NICE guideline Appendices I-O January 2016 Draft for consultation Commissioned
Timing of Vasopressors in Septic Shock: How Soon is Too Soon?
Timing of Vasopressors in Septic Shock: How Soon is Too Soon? Anand Kumar, MD Sections of Critical Care Medicine and Infectious Diseases Professor of Medicine, Medical Microbiology and Pharmacology University
Anaesthesia for the Over 75s. Chris Edge
Anaesthesia for the Over 75s Chris Edge Topics to be Covered Post-operative cognitive management Morbidity and mortality General anaesthesia a good idea or not? Multiple comorbidities and assessment of
Updates in Critical Care Sepsis, Fluids, Epi and Long-Term Outcomes
Updates in Critical Care Sepsis, Fluids, Epi and Long-Term Outcomes Matt Anderson, MD USD SSOM, Clinical Assistant Professor Regional Health, Critical Care Medicine mjanderson972@gmail.com Disclosure(s)
A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit
The new england journal of medicine original article A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit The SAFE Study Investigators* abstract background It remains uncertain
The relative merits of colloids or noncolloidal salt
Safety of Modern Starches Used During Surgery Philippe Van Der Linden, MD, PhD,* Michael James, MB ChB, PhD, FRCA, FCA(SA), Michael Mythen, MD FRCA, and Richard B. Weiskopf, MD E REVIEW ARTICLE Various
DIAGRAM OF THE PRESENTATION. Post ICU Rehabilitation. Effective strategies in ICU. During two last decades
1 1st European Conference on Weaning & Rehabilitation in Critically ill Patients INTERNATIONAL EARLY MOBILISATION NETWORK Post ICU Rehabilitation Serafeim N. Nanas Professor of Critical Care Medicine Evaggelismos
Novel Sepsis Therapies
RSEM-GSA 17 Novel Sepsis Therapies Khaled Ahmed Alghamdi, MD, ABEM, FACEP, FAAEM Consultant Emergency Medicine Deputy program director Medical Director of Emergency Medical Services King Faisal Specialist
ACUTE KIDNEY INJURY. Stuart Linas U. Colorado SOM
ACUTE KIDNEY INJURY Stuart Linas U. Colorado SOM Marked increases in incidence of dialysis-requiring AKI in last decade JASN 24 37 2013 Question 1 Of patients who recover from an episode of AKI, what percentage
Inhaled nitric oxide: clinical evidence for use in adults
Inhaled nitric oxide: clinical evidence for use in adults Neill Adhikari Critical Care Medicine Sunnybrook Health Sciences Centre and University of Toronto 31 October 2014 Conflict of interest Ikaria provided
DELIRIUM IN ICU: Prevention and Management. Milind Baldi
DELIRIUM IN ICU: Prevention and Management Milind Baldi Contents Introduction Risk factors Assessment Prevention Management Introduction Delirium is a syndrome characterized by acute cerebral dysfunction
Disclosures. Acute Kidney Injury. Outline. Do electronic alerts improve the care of patients with AKI? 5/9/2015
Disclosures Acute Kidney Injury Kathleen D. Liu, MD, PhD May 2015 Consultant: Achaogen, Chemocentryx, Durect, Z Pharma Clinical trials adjudication: Astute Funding: NIH Stockholder: Amgen Outline patients
Vasopressori ed Antiaritmici
Vasopressori ed Antiaritmici cosa e quando? Claudio Sandroni Istituto Anestesiologia e Rianimazione UCSC ILCOR ALS Task Force - ERC ALS Working Group Deputy Chair, ESICM TEM Section COI Co-author, ERC
Septic AKI in ICU patients
Septic AKI in ICU patients Prof. Achim Jörres, M.D. Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum Berlin, Germany achim.joerres@charite.de Agenda Epidemiology
Intravenous fluid selection rationales in acute clinical management
Original Article 13 Intravenous fluid selection rationales in acute clinical management Wing Yan Shirley Cheung, Wai Kwan Cheung, Chun Ho Lam, Yeuk Wai Chan, Hau Ching Chow, Ka Lok Cheng, Yau Hang Wong,
Vasopressors for shock
Vasopressors for shock Background Reviews and Observational Studies Holler 2015. Nontraumatic Hypotension and Shock in the Emergency Department and Prehospital Setting Prevalence, Etiology and Mortality:
Deepika Reddy MD Department of Endocrinology
Deepika Reddy MD Department of Endocrinology Management of hyperglycemic crisis Review need for inpatient glycemic control Brief overview of relevant trials Case based review of diabetes management strategies/review
Fluid bolus of 20% Albumin in post-cardiac surgical patient: a prospective observational study of effect duration
Fluid bolus of 20% Albumin in post-cardiac surgical patient: a prospective observational study of effect duration Investigators: Salvatore Cutuli, Eduardo Osawa, Rinaldo Bellomo Affiliations: 1. Department
Blood Transfusion Project. Reducing Transfusion in the MARCQI Population
Blood Transfusion Project Reducing Transfusion in the MARCQI Population Anemia in Healthy Awake Volunteers Critical hemoglobin threshold unknown in humans At 6 g/dl Decline in cognitive function At 5 g/dl
L uso appropriato dell albumina nel trattamento del paziente settico
Uso appropriato dell Albumina nella Cirrosi Epatica: le raccomandazioni AISF-SIMTI Istituto Superiore di Sanità, Roma Martedì 29 Marzo, 2016 L uso appropriato dell albumina nel trattamento del paziente
Primary fluid bolus therapy for infection-associated
Primary fluid bolus therapy for infection-associated hypotension in the emergency department Miklos Lipcsey, Jonathan Chiong, Ivan Subiakto, Melissa A Kaufman, Antoine G Schneider and Rinaldo Bellomo Hypotensive